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In  several experimental systems  the full expression of  the  antibody response  to 
certain antigens includes the participation of at least two cell types (e.g.,  1-4). The 
impaired response of thymectomized mice to sheep erythrocytes (SRBC)' is restored 
to normal by injections of thymus or thoracic duct cells  yet the reconstitutive inoculum 
(T  cell population)  does not contribute the precursors of  detectable direct plaque- 
forming cells (PFC) in the spleen. Such precursors (B cell population) may be provided 
directly, or after some period of maturation, by cells contained in the bone marrow 
(1). Furthermore, low levels of anti SRBC antibody or small numbers of direct PFC 
are produced by mixed inocula of thymus and marrow cells in lethally irradiated mice 
(3). Responses in these instances do not approach those in normal mice but here again 
the marrow cells provide the majority, if not all, the precursors of direct PFC  (5, 6). 
Thus, antibody production by B cells against antigens such as SRBC is facilitated by 
the presence of T  cells which themselves are likely to have had their ancestry in the 
cell population of the bone marrow (7). 
Understanding the mechanism of interaction between T  and B cells would be aided 
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1  Abbreviations used in this paper: anti a, antiserum to Igl ~, Ig4  a allotypes; anti b,  anti- 
serum to Igl  b, Ig4  b allotypes; Anti 0, AKR/J anti C3H/HeJ  thymus cclls; B  cells,  bone 
marrow-derived; CSM, cell-suspending  medium  (see footnote 12); FCS, fetal calf  serum; 
GPS, guinea pig serum; HRBC, horse red blood cells; MEM-PM, Eagle's minimal essential 
medium  (see footnote 8); NMS, normal AKR/J mouse serum; PFC, plaque-forming  cells; 
RAM')'G, rabbit anti-mouse gamma globulin  serum;  SRBC,  sheep  red blood cells;  STx, 
sham thymectomized; T cells, thymus-derived; TDC, thoracic duct cells; Tx, thymectomized. 
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by  clear  evidence  regarding  specificity in  both  cell  lines.  Specific immunological 
tolerance appears to be a property of both cell types (8, 9) even though many systems 
have provided evidence for tolerance in T  cells only (4,  10, 11). Only suggestive evi- 
dence is available on the question of whether adoptive immunological memory is car- 
ried by both cell populations. Specific immunological memory, involving heightened 
indirect PFC production, cannot be a property confined to T  cells (12) yet the results 
of Cunningham  (6), Raft  (13), and  evidence for "education"  (14,  15)  and  antigen- 
mediated proliferation of T  cells (2), suggest that these cells, as well as B  cells, may 
exhibit secondary responsiveness. 
The mouse alloantigen theta  (0)  is expressed maximally on thymus lymphocytes 
and  in brain tissue and  to  a  lesser extent on lymphocytes in peripheral lymphoid 
organs such  as the spleen and lymph nodes  (16,  17).  A  clear-cut reduction  in  the 
anti--0 serum sensitivity of peripheral lymphocytes from thymectomized or athymic 
"nude" mice (18,  19)  strongly suggests, but certainly does not prove, that 0 may be 
used as a marker for lymphoid cells previously influenced by the thymus, i.e., T  cells. 
Previous  work  in  these  laboratories  has  demonstrated  that  the  in  vitro 
immune response of normal mouse spleen cells to SRBC is reduced dramatically 
by  anti-0  serum  treatment  in  the  presence  of complement  and  that  this  re- 
sponse can be restored to control levels by in vivo incubated (educated) thymus 
cells (20). Anti-0 serum and complement did not affect the number of splenic 
hemopoietic stern cells, direct and indirect PFC  themselves, or the precursors 
of direct PFC generated in vitro. The availability of cytotoxic Anti 0, congenic 
C3H.SW and CWB  mice (which as far as can be determined differ genetically 
in immunoglobulin allotype only)  (21),  and  specific anti-allotype sera,  led to 
attempts  to  dissect  the  cellular  events  of  adoptive  secondary  responses  in 
mice.  The  results  of  this  study indicate  that  both  T  and  B  cells behave  as 
specifically hyperreative cell populations, and thus carry memory, after expo- 
sure to heterologous erythrocyte antigens. 
Materials and Methods 
Mice.--Male and female  mice of the C3H.SW/SnHz strain (tt-2 b, Ig ~, OC3H) and the 
congenic partner, C3H.SW-/gb(CWB) derived from either the 8th (CWB/8) or 13th (CWB/ 
13) backcross generations (21), were used in most experiments.  AKR/~[ and C3H/HeJ male 
mice, used for the production of AKR anti 0 C3H sera, were purchased from the Jackson 
Laboratories, Bar Harbor, Maine, and maintained in Berkeley.  BALB/eN and C57BL/10J- 
3/b, p/p, a  strain designated BCT, were raised and maintained in the colony of Dr. L. A. 
Herzenberg at Stanford. All mice were fed Mouse Chow 2 and water ad libitum and, in the case 
of mice at Stanford, were vaccinated with mouse pox vaccine s soon after weaning. Donors of 
thymus cells were always 4-6 wk old, and mice used for irradiation varied in age from 10 wk 
to 6 months. 
Irradiation.--Irradiation  procedures have been  described  in a  previous paper  (22), the 
2 Dean's Animal Feed, San Carlos, Calif. 
s Mouse Pox Service Laboratory (US Public Health Service), New Jersey College of Medi- 
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dose being 720-850 rads depending on the age and the size of the mice. 1 day before irradi- 
ation, and for the duration of life of the irradiated mice, antibiotics were given in the drinking 
water at doses of 1.13 g of neomycin sulfate and 113 mg of polymyxin B sulfate/liter. 
Call Suspensions.--Single  cell suspensions of spleen and thymus were prepared and counted 
as described previously except that organs were disrupted and teased through 50-mesh stain- 
less steel screens rather than pressed through with the rounded end of a test tube (22).  Care 
was taken to ensure that all thymuses were removed from the mice in a  bloodless field and 
all fascial tags dissected away from the lobes. Thoracic duct cells were collected into Dul- 
becco's phosphate-buffered saline (23) containing 5% fetal calf serum (FCS) 4 and 50-100 IU 
preservative-free  heparin.  5  Cannulation  of  mouse  thoracic  ducts  was  performed  using  a 
modified method of Boak and Woodruff (24) and the mice restrained postoperatively on exer- 
cise wheels. 
Antigens  and Immunlzatlon.--The  dose of SRBC  and horse erythrocytes  (HRBC)  used 
most frequently was 4  X  108 cells.  SRBC in Alsever's solution  6 and HRBC in Alsever's solu- 
tion  7 were washed three times in saline and resuspended finally in MEM-PM.  8 Most of  the 
immune mice to be used as spleen cell donors were injected with SRBC or HRBC intravenously 
and/or intraperitoneally followed, on the same day, by 10 or 20 #g of Piromen endotoxin  9 
intraperitoneally. 
Assay for PFC.--The modified assay of Jerne et al. (25) for detecting hemolytic antibody- 
producing cells in  agarose  has been described in  detail  in previous papers  (22,  26).  Indi- 
rect PFC were developed with anti-allotype sera as well  as a polyvalent rabbit anti-mouse 
gamma globulin serum  (RAM'yG).  The  anti-allotype  sera  used  in  this  study  (anti  Igl a, 
anti Ig4 a  and  anti  Igl b,  anti  Ig4  b  hereafter  referred  to  as  anti  a  and  anti  b)  reacted 
with both ~/G2a and "YG1 immunoglobulins in assays involving precipitation of 125I proteins 
(22).  The  number  of  indirect PFC  was  estimated  by  subtracting the number of PFC  on 
slides incubated with normal  mouse serum  (1:150)  from  the number on slides incubated 
with the developing anti-allotype sera (1:300 for anti a and 1:200 for anti b) or RAM'vG se- 
rum  (1:1000).  The  average  number  of  plaques  on  two  slides  incubated  with  developing 
sera (indirect PFC) was not considered to be above the average number on two slides incu- 
bated with normal mouse serum (direct PFC)  unless  the indirect PFC  number on  both of 
the slides was greater than the higher number of direct PFC. 
Production of Anti-8 Serum.--AKR/J  mice were injected intraperitoneally with dissoci- 
ated C3H/HeJ thymus cells in balanced salt solution (23).  The first bleedings were made 7 
and 14 days after six weekly injections of 2  X  107 thymus cells.  Subsequent bleedings were 
performed 7 and 14 days after single booster injections given at 3-wk intervals. Pooled sera 
obtained at each bleeding were tested for their capacity to inhibit an in vitro primary response 
to SRBC and for lack of cytotoxicity against direct PFC  (20).  AKR and C3H strains possess 
4 Immunoprecipitin-tested fetal  calf  serum,  Grand  Island  Biological  Company,  Grand 
Island, N. Y., and Berkeley, Calif. 
5 Hepathrom, Fellows Medical Manufacturing Company, Inc., Anaheim, Calif. 
6 Sterile sheep blood in modified Alsever's solution, W.  T.  Bennett Ranch Laboratory, 
Woodland, Calif. 
7 Palomino sterile horse blood in modified Alsever's solution, Colorado  Serum Company 
Laboratories, Denver, Colo. 
s Eagle's minimal essential medium,  catalogue No.  F-12.  Instant tissue  culture  powder 
medium without NaHCO3  (Grand  Island Biological Company,  Oakland,  Calif.)  made  up 
with  Na2HPO4-12H20  (0.001 M)  and  MgCI2-6H20  (0.001 ~t)  instead  of  bicarbonate  in 
deionized water. 
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different alleles at the Ly-A  locus (27)  and AKR anti C3H thymus cell sera  (Anti 0)  could 
contain anti-Ly-A.1  antibodies (19).  Anti 0 prepared as indicated above was absorbed with 
BALB/c  (0C3H,  Ly-A.2)  thymus  cells  and  tested  against  SICr-labeled  thymus  cells  (see 
below) from C3It.SW and C57BL/10 (BCT) mice. As seen in Table I, BALB/c thymus cells 
(but not AKR/J thymus cells) absorbed out the cytotoxie activity of our Anti 0 for thymus 
cells.  Thus, the eytotoxicity of this antiserum is not due to the presence of anfi-Ly-A .I anti- 
bodies. 
In Vitro Treatment of Cells with Anti-O Serum.--Single  cell suspensions at a final cell concen- 
tration of 1 X  10  7 nucleated cells/ml were  incubated with Anti 0 or normal AKR/J  mouse 
TABLE  I 
Absorption of Cytotoxic Activity  of Anti 0 w#h Thymus  Cells 
Donor of ~lCr thymus cells 
C3H.SW 
C57BL/10 (BCT) 
Donor of thymus cells used for 
absorption  of Anti 0  Cytotoxic  index*  (~) 
--  77.5 
BALB/c$  0.3 
AKR/J  69.7 
--  72.2 
BALB/c  0.9 
AKR/J  64.0 
* Ratio, expressed as a  percentage,  of  the number of counts released with Anti 0  (1:80 
final  dilution)  and  GPS  (1:10  final  dilution)  minus  the  number  of  counts  released  with 
GPS  to  the  number  of  counts  released  by  freezing  and  thawing  minus  the  number  of 
counts released with GPS.  Indices are  calculated frmn  the average  of  supernatant counts 
from two duplicate  tubes.  Treatment  of  labeled C3H.SW  and  C57BL/10  (BCT)  thymus 
cells with normal  AKR/J  serum  and  GPS  resulted  in  cytotoxic  indices  of  0  and  0.9%, 
respectively. Labeled cells were incubated with Anti 0 or AKR/J serum before adding GPS. 
:~ Anti 0  was  absorbed three  times with an equal volume of packed  thymus cells.  The 
serum and cells were mixed at  each  step,  and  the plastic  tubes  left  for  20  rain  in  an  ice 
bucket before centrifugation and removal of supernatant. 
sera (NMS)  (at a  final concentration of 1:40)  and guinea pig serum  (GPS) 1°  (1:10 final) in 
5%  FCS  in MEM-PM  for 45  min at 37°C.  After centrifugatlon the  cells were  suspended 
and washed in a  large volume of 5% FCS in MEM-PM. The cells were finally resuspended 
in MEM-PM, counted, and the volume adjusted to provide the required number of cells in 
0.1-0.5 ml. The GPS, used as a source of complement, was absorbed immediately before use 
with either acetone-treated  liver and  lymphoid  tissue powder  (20  mg/ml)  or agarose  tl  (80 
mg/ml)  for periods of  1-3 hr in an ice bath  (the latter procedure was  suggested  to us by 
Dr. M. Schlesinger). 
51Cr Release Assay.--Thymus cells, suspended in 5% FCS in 3'IEM-PM or cell-suspending 
medium  (CSM) 12  at a  concentration of  10  a  nucleated cells/m[, were  incubated with  occa- 
sional shaking at 37°C  for 30-60 min with 100 uCi Na251CrO413/ml.  Cells were washed three 
i0 Dried complement (guinea pig), Hyland Laboratories, Costa Mesa, Calif. 
it SeaKem, M[ariue Colloids Inc., Springfield, N. J. 
12 Cell-suspending medium consisting of Grand Island Biological Company medium  199, 
catalogue No.  El2, plus 0.35  g/liter NaHCO3 and penicillin and  streptomycin (100 IU/ml). 
13 New England Nuclear Corporation, Boston, Mass. Specific  activity of 80--400 mCi/mg. MITCHELL  ET  AL.  169 
times in excess CSM or MEM-PM containing FCS and suspended finally at a concentration 
of l0  s cells/ml. 1 million cells  (10  t*l) were added  to each tube in the assay  together with 
80  t*l of CSM or MEM-PM plus FCS and 10 t*l of the test antiserum dilution. The mixture 
was incubated for 30-45  rain at 37°C,  spun in a  Beckman serofuge (Beckman Instruments, 
Inc., Fullerton, Calif.) for 10 sec, the supernatant discarded, and 100 t*l of 1:6 or 1 : 10 agarose- 
absorbed  GPS added to each tube.  After a  further incubation of 30 rain at 37°C,  25 td was 
sampled into  tubes,  in some cases containing 0.2  ml of saline, and  counted  in a  well-type 
gamma  scintillation counter.  Controls,  run  in parallel,  were cells incubated  without  GPS, 
the appropriate  dilution of NMS, or with NMS plus GPS. Other aliquots of 106 cells were 
frozen and thawed three times in a freezing mixture of acetone-dry ice. The cytotoxic index 
was computed using the formula: 
counts released with Anti 0 and  GPS  -  counts  released with  GPS 
X  100. 
counts  released with freezing and thawing  --  counts released with  GPS 
Statistical Analysis.--The geometric means and limits of the standard  error of the means 
were determined from log10 transformed data using a program on the Stanford Acme computer. 
.P values were determined by Student's t test using a formula for small group sizes and a one- 
tailed test. When comparing the values of two means in this test, a figure of 0.05 was chosen 
as the limit of statistical significance. 
Experimental Design.--The overall plan of the experiments is indicated in Fig.  1.  Spleen 
cells from immunized C3H.SW mice, after incubation with Anti 0 +  GPS, NMS +  Gps, or 
after  no  incubation,  were  transferred  to heavily irradiated  CWB  recipients  together  with 
heterologous erythrocytes by intravenous injection. Splenic PFC numbers were  determined 
7 days later,  the indirect PFC  being developed with three antisera:  anti a  allotype, anti b 
allotype, and RAM~'G. In some cases,  inocula of spleen cells treated in vitro with Anti 0 + 
GPS were supplemented with dissociated thymus or thoracic duct cells from CWB mice. 
RESULTS 
Preliminary Experiment.- 
Specificity of the Adoptive Secondary Response to Heterologous Erythrocytes.-- 
Lethally  irradiated  CWB  mice  were  injected  with  either  4  X  l0  s  SRBC  or 
HRBC  together with a  small number  (4 million) of spleen cells from uninjected 
CWB  mice  or mice  injected  12  wk  previously  with  either  4  X  l0  s  SRBC  or 
HRBC  intravenously  and  10  #g  of  endotoxin  intraperitoneal!y.  PFC  assays 
were performed on pooled spleen cells 7  days  later and  results  are presented  in 
Table  II.  Indirect  PFC  were  developed  with  RAM-),G.  It  is  apparent  that  4 
million  spleen  cells from  SRBC-immune  mice  gave  rise  to  a  large  number  of 
indirect  anti  SRBC  PFC,  but  not  anti  HRBC  PFC,  in  irradiated  recipients 
injected  with  SRBC.  Neither  indirect  anti  SRBC  nor  anti  HRBC  PFC  were 
apparent in the spleens of irradiated recipients injected with HRBC  and spleen 
cells  from  SRBC-immune  mice.  Similarly,  spleen  cells  from  HRBC-immune 
mice  transferred  an  impressive  indirect  PFC  response  to  HRBC  and  not  to 
SRBC.  Thus,  in  all  groups  of  irradiated  recipients  of  cells  from  immunized 
donors,  significant  numbers  of indirect  PFC  were  obtained  only when  spleen 
cells  were  injected  with  the  antigen  against  which  the  donors  had  been  ira- 170  IMMUNOLOGICAL MEMORY IN  MICE. III 
munized and only when the recipient spleens were assayed against that particu- 
lar antigen. 
4 million spleen cells from uninjected CWB mice did not give rise to indirect 
PFC in recipient spleens. Some direct PFC were detected in spleens of recipients 
C3H.SW  (Ig  a) 
Immunize  i  Sheep or horse erythrocytes 
Wait  ~  6-36 wk 
Spleen cell suspension  (J 
Incubate with 
Wash, count 
Supplement 
Inject i.v. 
with 4 X  10  s 
erythrocytes 
None 
Anti 0 serum 
+  guinea pig 
serum 
CWB (Ig  b) 
thymus 
or 
thoracic 
duct 
cells 
Normal mouse serum 
+  guinea pig serum 
None 
CWB (Ig  b) irradiated  recipients 
No incubation 
None 
!  i 
Determine direct, Ig% Ig  b, and total "yG PFC on day 7 
FIc.  1.  Experimental  plan  to  test  for  inhibition  of adoptive  secondary  response  with 
Anti 0 serum and restoration by thymus and thoracic duct cells. 
of  spleen  ceils  and  SRBC,  but  not  in  recipients  of  spleen  cells  and  HRBC 
unless  the  donors  had  been  immunized  against  HRBC.  These  direct  PFC 
responses are low and will not be discussed further in this consideration of the 
adoptive secondary, indirect PFC  response,  In two other experiments  (results 
not  shown)  3-5  million  spleen  cells  from  uninjected  C3H.SW  mice  also  re- 
sulted in direct PFC (<400/spleen)  but not indirect PFC to SRBC. Thus, the MITCn~ELL ET  AL.  171 
impressive 7-day indirect PFC response, after transfer of a  limited number  of 
spleen cells from  primed donors,  is indeed  a  specific, adoptive  secondary re- 
sponse. 
Preliminary Experiment.- 
Dose Effect of Spleen Cells in the Transfer System.--Spleen cells from C3H.SW 
mice injected 28  wk previously with  4  X  l0  s  SRBC  and  20  #g  of  endotoxin 
TABLE II 
Specificity of Adoptive Secondary Response to  Heterologous Erythrocytes 
Spleen cell donor  Spleen cell recipients~  PFC (X10-2)  per spleen at 7 days§ 
Secondary  No. of  Anti SRBC  Anti HRBC  Primary erythrocyte 
challenge*  erythrocyte  recipientsll  challenge  Direct  Indirect  Direct  Indirect 
Sheep (SRBC)  Sheep  4  4.41[  30  < 1  ¶  < 1 
Horse  4  < 1  < 1  < 1  < 1 
Horse (HRBC)  Horse  4  < 1  1.9"*  2.6  87 
Sheep  4  2.8  < 1  < 1  < 1 
None  Sheep  4  < 1  < 1  < 1  < 1 
Horse  4  < 1  < 1  < 1  < 1 
* Primed donor  (CWB) mice were injected 12 wk before transfer with (4 X  10  s) sheep  or 
horse erythrocytes and  10 #g of endotoxin.  Spleens from  three mice were pooled  for  each 
transfer. 
:~ 4 )< 106 nucleated spleen cells were injected i.v. together with 4 >( 108 erythrocytes from 
sheep or horse. 
§ PFC: Direct plaques require no developing antisera. The rabbit anti-mouse 3'G anti- 
serum used to develop indirect plaques is described in Materials and Methods Section. 
I1 Spleens  of recipients were pooled before plaque assay. 
¶ No PFC on slides when  1% of nucleated spleen cells in the suspension were plated, i.e., 
< 100 PFC/spleen. In these experiments, pools of three to five spleens  from  irradiated mice 
injected with SRBC  or HRBC alone contained an average of < 10 direct and indirect PFC 
per spleen. 
** These plaques were relatively  large areas of partial hemolysis. 
intraperitoneally were incubated with Anti 0  or NMS  together with absorbed 
GPS as a  source of complement. The incubated cells were washed, counted, and 
1-16  million nucleated  cells injected  into  groups  of  three  lethally irradiated 
CWB  mice together with 4  X  10 ~ SRBC  intravenously. The  results of PFC 
assays performed 7  days later are shown in Fig. 2. Treatment with Anti 0  + 
GPS  (cf.  treatment  with  NMS  +  GPS)  reduced  direct  (not  shown)  and  in- 
direct PFC  responses to  a  constant  dose  of  SRBC  regardless of  the  number 
of treated spleen cells injected. The  number  of nucleated cells per spleen was 
decreased in  recipients of low numbers  of  spleen cells treated with Anti 0  + 172  IMMUNOLOGICAL  MEMORY  IN  MICE.  III 
GPS  (Fig.  2).  This  effect was also noticed in  several  subsequent  experiments 
in which cell counts were performed at the time of PFC assay. The number of 
cells in spleens of recipients of 3 million spleen cells treated with NMS +  GPS 
was 26.3 4-  1.7 million and 15.7 4-  1.7 million  (six experiments)  in the case of 
recipients of cells treated with Anti 0 4- GPS (P <  0.005). 
In  another  experiment,  spleen  cells  from  two  normal  C3H.SW  mice  were 
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FIG.  2.  Cell dose dependence  of 7-day adoptive  secondary  PFC  response.  Spleen cells 
from  SRBC-primed  C3H.SW mice were treated  with  NMS +  GPS  (circles) or Anti 0 + 
GPS (triangles) and injected into irradiated  CWB recipients. The points  are mean responses 
of groups of three  mice; solid symbols  represent  total  indirect  SRBC  PFC  developed with 
RAM3'G;  open  symbols  represent  indirect  SRBC  PFC  developed with  anti  a  (cell donor) 
allotype  sera. Inset: the mean number  of nucleated cells per spleen (X 10  -6) at 7 days after 
transfer  of treated  spleen cells. 
pooled, treated with  NMS -t- GPS or Anti 0 +  GPS, and 1 million washed cells 
injected  into  irradiated  CWB  recipients.  Hemopoietic  colonies  in  recipient 
spleens were counted 8 days later after fixation of the spleens in Bouin's solu- 
tion  (28).  The number  of splenic  colonies in recipients  of spleen  cells  treated 
with NMS 4-  GPS was 5.3 4-  1.0 (four mice) ; the number in recipients of cells 
treated  with  Anti 0  +  GPS  was 9.2  4-  1.7  (five mice).  This  difference is  not 
significant.  The  spleens  of  three  irradiated  control  mice,  not  injected  with 
spleen  cells,  contained  a  single  colony. Hence,  splenic  hemopoietic stem  cells 
of C3H.SW mice like those of C57BL mice (20)  are not detectably sensitive to MITCHELL  ET  AL.  173 
treatment with Anti 0  +  GPS. In  all  experiments to be described,  doses of 
treated spleen cells ranging in number from 1-5 million were used in order to 
conserve anti-0 serum. 
Inhibition of the Adoptive Secondary Response to SRBC Using Anti 0 + GPS.-- 
C3H.SW mice, injected 9-36 wk previously with SRBC and  endotoxin, were 
killed,  their spleens removed, and  the cells incubated in  vitro with NMS  + 
GPS or Anti 0 +  GPS. After washing and counting, 1-5 million nucleated cells 
were injected intravenously into lethally irradiated CWB  mice together with 
4 X  108 SRBC. The numbers of direct and indirect PFC in the spleens of these 
recipients, at 7 days after irradiation, are shown in Table III. In all six experi- 
ments, treatment of cells with Anti 0 +  GPS markedly reduced 7-day indirect 
PFC  responses  when  compared  with  responses  in  recipients  of  spleen  cells 
treated in vitro with NMS  +  GPS or left untreated.  The magnitude of the 
reduction in indirect PFC number varied from 1-3 log10 units and, in the  one 
case  in  which  statistical  analysis  could  be  applied, the  differences in  mean 
numbers of PFC developed with both anti a allotype and RAM'yG were signifi- 
cant  (P  <  0.01).  The  irradiated  CWB  hosts  did  not  contribute  PFC  pre- 
cursors (b allotype) and b-allotype PFC were detected only in the one experi- 
ment in  which  spleen cells from SRBC-immune  CWB  mice were transfered. 
Again, Anti 0 +  GPS treatment reduced the adoptive secondary response by a 
factor of more than  1 log10. In these experiments, as well as others (12,  22), 
RAM3,G was more effective at developing PFC than anti-allotype sera. This 
probably reflects the contribution of a higher titer, or wider spectrum, of rabbit 
antibodies directed against immunoglobulin products of PFC. Emphasis in the 
analyses of the results of these and subsequent experiments will be on allotype 
PFC  since these identify PFC as being of either C3H.SW or CWB  type (see 
Discussion). 
Reconstitution of the Impaired Adoptive Secondary Response Using Thymus 
Cells.--A  reduction in the response of antiserum-treated spleen cells does not 
discriminate between an effect of the treatment on T cells or an effect on B cells. 
To determine whether PFC precursors (B cells) were affected by Anti 0 d- GPS 
treatment, attempts were made to reconstitute the adoptive response of spleen 
cells from mice of one immunoglobulin allotype using thymus cells from normal 
donors  of  the  other allotype. The  results  of four  experiments are  shown  in 
Table IV:  two using  spleen cells from SRBC-immune  C3H.SW  and  thymus 
cells from normal CWB, one using spleen cells from SRBC-immune CWB and 
thymus cells from normal C3H.SW, and another using spleen cells and thymus 
cells from (C57BL/10  [BCT]  X  BALB/c)F1 mice. In  the  three experiments 
involving congenic mice, (in which antisera against allotypic immunoglobulin 
markers could be used) it is clear that  the reduced indirect PFC  response of 
Anti 0-treated spleen cells can be restored to control levels by thymus cells 
which do not themselves develop into detectable indirect PFC. In the cases in 174  IMMUNOLOGICAL  MEMORY  IN  MICE.  III 
which  PFC  determinations  were performed on individual  spleens,  significant 
differences were observed between  the mean numbers  of indirect  PFC in re- 
cipients of spleen cells after Anti 0 +  GPS treatment and either NMS +  GPS 
TABLE III 
Inhibition  of Adoptive Secondary SRBC Response in  Mice Receiving Primed  Spleen  Cells 
Depleted of O-Positive Calls 
Spleen cell 
donors 
(SRBC 
primed)* 
wk 
C3H.SW  9  None 
(Ig  a)  NMS 
Anti 0 
C3H.SW  17  None 
(Ig  a)  NMS 
Anti 0 
C3H.SW  18  None 
(Ig  a)  NMS 
Anti 0 
C3H.SW  19  None 
(Ig  a)  NMS 
Anti 0 
CWB  ,32  NMS 
(Ig  b)  Anti 0 
C3H.SW  36  None 
(Ig  a)  NMS 
Anti 0 
r 
After  ]  No. of 
pri-  [  ScPell~en  irradi- 
mary  [  In vitro  ~i~0~d)  ated 
injec-  treat-  CWB 
tion of [  ment:~  (Ig ~) 
(  recipi- 
SRBC  ents§ 
3.0 
1.5 
1.0 
2.0 
3.0 
5.0 
Anti sheep PFC  (X10-2) per spleen at 7 daysll 
Direct  Allotype Ig  a 
< 1¶  12 
3.5  41 
<1  <1 
<1  48 
9.6  70 
<1  <1 
4.2  24 
5  5l 
<1  <l 
1.8  62 
7.7  102 
<1  6  (3.7  9.8) 
37  <1 
1.3  <1 
10  (7.7-14)  28,5  (201-40,3) 
16  (12-20)  136  (94-198) 
<I  18  (12-26) 
Allo- 
type  Total 7G 
Ig  b 
<1  24 
<1  51 
<i  1.2 
<1  99 
<1  120 
<1  2  (0,6  8.4)** 
<1  25 
<1  58 
<1  <1 
<1  103 
<1  233 
<1  9  (6, 8-12) 
61  273 
2  5 
<l  371  (318-432) 
<1  207  (158-271) 
<1  24  (15-38) 
* Donor mice received 4  8 X  10 s SRBC i.v. and/or i.p. and 20/~g of endotoxin  i.p. Pools of spleen cells from 
two or three mice were used for transfer in each experiment. 
When ceils were incubated  with NMS  (normal AKR/J  serum)  or Anti 0  (AKR/J  anti  C3H/HeJ  thymus 
cells), guinea pig serum (complement source) was always present. 
§ Spleens of recipients were pooled before plaque assay except where standard  error limits appear in paren- 
thesis next to  the number of PFC per spleen. 
[] PFC: Direct plaques require no developing antisera. The anti-allotype  and rabbit anti-mouse TG antisera 
used to develop indirect plaques are described in Materials and Methods  Section. 
¶  No PFC on slides when 1% of nucleated spleen cells in the suspension were plated,  i.e.,  < 100 PFC/spleen. 
In these experiments, pools of three to five spleens from irradiated mice injected with SRBC alone contained an 
average of <100 direct and indirect PFC per spleen. 
** Geometric mean (~ standard  error). Where standard error appears, spleens of animals in the group were 
tested individually. 
treatment or Anti 0 +  GPS treatment but with a supplement of thymus cells 
(P <  0.025). In the experiment involving FI mice, the donors were immunized 
with low dose SRBC in the absence of endotoxin and the spleen cells used 4 wk 
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derivation,  the  results  of PFC  determinations parallel  results in the experi- 
ments using congenic strains of mice and a priming regime of high-dose SRBC 
plus endotoxin. In one experiment (results not shown)  the response of CWB 
spleen cells treated with NMS -b  GPS was not increased  by a  supplement of 
TABLE IV 
Restoration, by Thymus Cells, of the Adoptive Secondary SRBC Response of Primed Spleen Celia 
Depleted of P-Positive Cells 
Spleen cell 
donors 
(SRBC 
primed)* 
A 
C3H.SW 
(Ig  a) 
B 
C3H.SW 
(Ig  a) 
C 
CWB 
(lg b) 
D 
(BCT X 
BALB/e)F1 
(Igb/Ig  a) 
Anti sheep PFC  (X10-~) per spleen at 
7 days[] 
Direct 
2.5(2-4)** 
<1 
3.2(2-4) 
1,5§ 
<1 
2 
<1 
5.6 
1 
15 (13-1s) 
3(.7-12) 
Total ~,G 
s9 (37-93) 
2.6(2--4) 
108(88-133) 
<1 
30 
2.5 
16 
<1 
48 
3.7 
.55 
<1 
9s (7o-129) 
<1 
82(57-119) 
<1 
Same as Table III except: 
* Primary injection, group A  =  8 X  108 SRBC i.v. and i.p. and 20/~g of endotoxin i.p. 
B  =  4 X  l0  s SRBC i.p. and 10/zg of endotoxin i.p. 
C  =  4 X  10  ~ SRBC i.p. and 20/~g of endotoxio i.p. 
D  =  4 X  108 SRBC i.v. and i.p. 
~  BCT X  BALB/c Fx (Igb/Iga)-irradiated recipients (syngeneic to thymus cell donors). 
70 X  106 C3H.SW thymus cells. The results of these experiments suggest that 
the precursors of PFC  (B  cells)  carry immunological memory but that  their 
expression as indirect PFC requires the presence of a cell population sensitive 
to Anti 0 +  GPS and which can be replaced functionally by T  cells. 
Reconstitution  of the Impaired  Adoptive Secondary  Response  Using  Thoracic 
Duct  Cells.--Moderately  large  doses  of  thymus  cells  from  normal  mice  re- 
stored the secondary responsiveness of treated cells from immunized mice (vide 176  IMMUNOLOGICAL  MEMORY  IN  MICE.  III 
supra).  It was of interest  to determine whether a  smaller  number of T  cells 
from primed  mice could restore  PFC production by spleen cells  treated  with 
TABLE  V 
Specificity qf Restoration by  Thoracic Duct Cells of  Adoptive Secondary Response to Horse 
Erythrocytes 
Spleen cell 
donors 
(tlRBC 
primed)* 
A 
C3tt.SW 
(Ig  a) 
B 
C 3H SW 
fig  ~) 
C 
C3H.SW 
(lg  ~) 
D 
C3II,SW 
Ig~q 
After  In vitro 
primary 
injection  treat- 
of HRBC I  ment~ 
.....  i 
wk 
11 
None 
NMS 
Anti 0 
NMS 
Anti 0 
Thoracic duct ceil 
No. of  ,  supplement 
Spleen  irradia-  i  (CWB donors)** 
cells  ted CWB  (Xl0  -G)  injected  fig  °) 
(XIO -~) [  recipi- 
ents§  No.  Primed 
with 
2.0 
3.0 
NMS  3.0 
Anti O  " 
.  a 
NMS  3.0 
Anti 0  " 
None 
None 
2.0 
None 
2.0 
r----  -- 
Anti-horse PFC  (X  I0-2)  per 
spleen at 6 days[l 
None 
2.5  HRBC 
0.5  H  " 
2.5  S  " 
7.5  S  " 
2.5  H  " 
2.5  S  " 
i 
Allo- 
Direct  type 
8.7  [  41 
2  43 
<1  <I 
Allo-  t 
type  I  Total 
Igb  /  ~Gj 
<1¶  55 
<1 
<1  <1 
4.7 
<1 
IIRBC  4.3 
S  "  1 
I1  "  <1 
S  "  < 1 
<I 
<1 
HRBC  4.4 
S  "  1.8 
tl  "  5.2 
]  S  "  <1  P 
<1 
1 
<1 
<1 
<1 
1.9 
<1 
<1 
56 
219  <1  409 
4.3  <1  16 
124  15  272 
19  <1  53 
<1  7  28 
<l  <1  3 
81  <1  143 
<1  <1  "<1 
113  10  367 
11  <1  21 
<1  7  33 
<1  <1  2 
2O  <1  31 
1  <1  1.2 
92  8.3  136 
10  <1  22 
6  <l  13 
51  7.4  10 
<1  1.3  3 
<1  <1  <1 
Same as Table lII except: 
* All animals received a primary injection of 4 X  10  s horse erythrocytes  (HRBC) i.p.; groups A, B, and  C 
received 20 #g of endotoxin at the same time while group D received 10/zg of endotoxin. 
¶  In these experiments, pools of three or four spleens from irradiated mice injected with HRBC alone con- 
tained <20 direct PFC per spleen and no indirect PFC. 
:~+* Donors of thoracic duct cells were primed with either 4 X  108 HRBC or SRBC and endotoxin at the same 
time as the spleen cell donors received tIRBC. 
Anti 0  +  GPS.  For these  experiments,  C3H.SW  mice,  injected  7,  9,  or ll  wk 
previously with 4  X  l0 s HRBC  and l0 or 20/zg of endotoxin intraperitoneally, 
were killed and pools of spleen cells incubated with Anti 0  -t-  GPS  or NMS  + 
GPS.  In  three experiments  (Table  V)  spleen cells  treated  with Anti 0  +  GPS MITCHELL ET AL.  177 
were  supplemented  ac  the  time  of  transfer with  thoracic  duct  cells  (TDC) 
from CWB mice injected 7, 9, or 11 wk previously with either 4 X  l0 s SI~BC or 
HRBC  and  10  or  20  /zg  of  endotoxin  intraperitoneally. In  all  experiments 
Anti 0 +  GPS treatment reduced the adoptive indirect PFC response to very 
low levels. A  supplement  of TDC,  whether from SRBC-immune  or HRBC- 
immune mice increased the response of spleen cells treated with Anti 0 +  GPS 
(as measured by the number of indirect PFC  developed with  anti a  allotype 
sera).  However, TDC  from HRBC-immune  mice  resulted  in  approximately 
ten  times  the  number  of  allotype-marked  PFC  as  did  TDC  from  SRBC- 
immune mice. Moreover, in one experiment, inocula of 0.5 and 2.5  X  106 TDC 
from HRBC-immune mice weremore effective than 2.5 and 7.5 X  106 TDC from 
SRBC-immune mice, respectively. As might be anticipated, TDC from HRBC- 
immune mice gave rise to a few allotype-marked (b-type) PFC whether or not 
they were injected together with treated spleen cells.  The experiments clearly 
indicate that thoracic duct cells,  when assayed for their T-cell activity, carry 
specific immunological  memory  in  that  they  are  able  to  facilitate  indirect 
PFC expression by B  cells contained in a  suspension of Anti 0-treated spleen 
cells from primed mice. 
In two experiments of the type described above (results not shown), groups 
of irradiated mice were injected with Anti 0-treated spleen cells from immune 
mice of a allotype together with TDC from mice of the  b  allotype immunized 
with the other erythrocyte type. These recipient mice were injected with SRBC 
+  HRBC.  There  was  no  significant  increase  in  either  a-allotype  PFC  or 
b-allotype  PFC,  when  compared  with  the  responses  in  mice  in- 
jected with one erythrocyte type and  a combination of spleen cells and TDC 
from mice immunized  with  different erythrocyte  types.  Thus,  T  cells from 
mice primed to one erythrocyte type when confronted with the antigen could 
not facilitate indirect PFC production by B cells from mice primed to the other 
erythrocyte type and confronted with that particular antigen. 
Susceptibility of a Supplement to Treatment  with Anti ~ +  GPS.--The finding 
that a cell population with T  cell activity is reconstitutive in this system indi- 
cates that cells sensitive to Anti ~ +  GPS  are replaced functionally by T  cells. 
It becomes important, however, to determine whether or not treatment with 
Anti ~ +  GPS will reduce the T  cell activity of a cell supplement. We chose to 
use spleen cells as the treated supplement simply because our incubation proce- 
dure had been developed with  spleen cells and  not  thymus or thoracic duct 
cells.  Spleen  cells from SRBC-immune  C3H.SW  mice were  treated  in  vitro 
with Anti ~ +  GPS and mixed with  spleen cells from SRBC-immune  CWB 
mice treated with  either Anti 0  +  GPS  or  NMS  +  GPS.  In  the  control 
groups,  treatment  with  Anti  e  +  GPS reduced the adoptive response of 3 
million spleen cells from either immune  C3H.SW  or immune  CWB  mice by 
15-  to  20-fold.  In  the  experimental  groups,  CWB  spleen cells  treated  with 
NMS +  GPS were six times better than CWB spleen cells treated with Anti 0 + 178  IMMUNOLOGICAL  MEMORY  IN  MICE.  III 
GPS  at  restoring the  a-type indirect PFC  response of C3H.SW  spleen cells 
treated with Anti 0 +  GPS. 
The above experiment indicates that cells sensitive to Anti 0 +  GPS in a 
supplement of spleen cells are required for the full expression of T cell cooperat- 
ing activity of that supplement. This is also the case in an in vitro system where 
treatment with Anti 0 +  GPS markedly reduced the ability of in vivo educated 
thymus cells to reconstitute the response of normal spleen cells treated with 
Anti 0 +  GPS (20). 
DISCUSSION 
Numerous studies have been addressed to the question of the cellular events 
of secondary antibody responses to erythrocyte antigens  (e.g. 5,  22,  29-34). 
Speculations on the life history of the cell which carries immunological memory 
must now take into account the finding of interacting cell types in the fully 
reconstituted primary response to SRBC in thymectomized mice (1). Is specific 
immunological  memory a  property which  can  be  linked  to  both  antibody- 
forming cell precursors (B cells)  and thymus-influenced cells (T cells)? Results 
of the present study indicate that this is so in the case of the adoptive secondary 
response to heterologous erythrocytes in mice. 
The primary in vitro (20,  35) and secondary in vivo (36)  and in vitro (20) 
responses to SRBC  can be inhibited by treatment of spleen cells with anti-0 
serum  and  guinea  pig  complement  (Anti  0  +  GPS).  Reeonstitution  with 
thymus cells [cf. educated thymus cells (20)] has not been reported. Before any 
statement can be made on the cellular site of action of the serum treatment, it is 
imperative to achieve reconstitution. Interpretations are restricted if it can be 
shown that reconstitution is possible with a cell type presumed to be related to 
that in the spleen cell population which is sensitive to Anti 0 +  GPS and that, in 
turn,  this  reconstitutive inoculum is  itself  sensitive  to Anti  0  +  GPS.  The 
data in Table IV indicates that  thymus cells from normal mice reconstitute 
the secondary responsiveness of spleen cells treated with Anti 0 +  GPS. Hence, 
a primed B cell population (B' cells)  must be present in spleen cell suspensions 
treated with Anti 0 +  GPS but this population is unable to express itself, in 
terms of indirect (7S)  PFC production, in the absence of another population 
sensitive to Anti 0 +  GPS. The cells of the latter population presumably bear 
the 0 surface alloantigen, are functionally inhibited or killed by Anti 0 +  GPS, 
and are functionally replaced by thymus cells. The adoptive secondary serum 
antibody response to polymerized flagellin from Salmonella adelaide is markedly 
impaired by treatment of spleen cells with Anti 0 +  GPS.  1~ In this system we 
have been unable to restore the response with large numbers of thymus cells, 
and therefore, it is not possible to say that Anti 0 +  GPS has no detectable 
effect on B cells primed to flagellin. 
14 Mitchell, G. F., E. L. Chan, and A. A. Amkmut. Unpublished data. MITCHELL ET AL.  179 
Thoracic duct cells from mice primed to HRBC were much better than an 
equivalent number of thoracic duct cells  from mice primed  to  SRBC in re- 
constituting the  B  cell  response  of treated spleen cells  from HRBC-immune 
mice (Table V). Thus, the T  cell population, like the B cell population, must 
be  altered  by  prior  contact  with  antigen  and  carry  specific  immunological 
memory (T'  cells).  Jacohson et  al.  (12)  demonstrated that,  in a  mixture of 
spleen cells from primed and unprimed mice, the indirect PFC were always of 
primed donor allotype. From this data and that in Table V, it is clear that 
primed T  cell  activity in the present system is not expressed in terms of ?S 
B cell memory [cf. 19S B  cell memory (6)] unless the latter cell population is 
also primed. 
With respect to the "factor of immunization" in each cell population, it is 
clear that moderately large numbers of thymus cells from unprimed mice and 
small  numbers  of  thoracic  duct  cells  from  nonspecifically primed  mice  are 
reconstitutive in  the  transfer  system. By contrast,  spleen cells,  when trans- 
ferred in small numbers must be obtained from specifically primed mice in order 
for any indirect PFC to be detected in irradiated recipients at day 7 after trans- 
fer. Hence, it may be that the "potency" of T cells is increased after priming by 
a factor of approximately 5- to 10-fold (Table V), whereas in B cells this factor 
may be much greater. However, a meaningful factor of immunization figure is 
impossible to calculate because of multiple uncontrolled variables such as time 
of PFC  assay and doses of antigen and endotoxin used. Moreover, it is not 
possible to control for complexities such as a disproportionate T  cell priming 
vs. B  cell priming by contact with environmental antigens before introducing 
the  heterologous erythrocytes. 
Anti 0 +  GPS does not affect the number of C3H.SW splenic hemopoietic 
stem cells,  but with small numbers of transferred cells  the sizes  of recipient 
spleens are significantly reduced. This difference in spleen cell number (twice at 
most)  does not account for the  difference in PFC  number in  the  spleens of 
recipients of cells treated with NMS +  GPS and Anti 0 +  GPS (ten times at 
least). The differential effect of treatment with Anti 0 +  GPS on splenic re- 
generation  compared  with  the  number  of  hemopoietic colony-forming units 
may be related to the observation that injected thymus cells facilitate erythro- 
poietic regeneration in irradiated mice (37). Alternatively, or in addition, 0-bear- 
ing cells may make up a large proportion of the cells in regenerating spleens of 
recipients of cells  treated with NMS  +  GPS.  The  increased  spleen  size  in 
recipients of NMS +  GPS treated cells (cf. Anti 0 +  GPS treated cells)  sug- 
gests that an interaction between T  cells,  B  cells,  and antigen enhances cell 
proliferation in general. 
No evidence could be obtained in the present study for a nonspecific influence 
of primed  T  cells,  injected  with  the  appropriate  antigen,  on  the  antibody- 
producing capacity of primed B  ceils.  For example, thoracic duct cells from 
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result in increased numbers of anti SRBC (a altotype) PFC produced by Anti 
0  -t-  GPS-treated  spleen  cells  from  SRBC-immune  C3H.SW  nfice.  Results 
obtained in an in vitro system [of. an in vivo system (11)],  similar in  design 
to  that described above, have been interpreted as evidence for a  nonspecific 
factor in interacting cell systems (38). 
Many of the above conclusions and considerations are dependent on several 
assumptions: (a) The assumption that cells of a particular Fc inmmnoglobulin 
allotype will continue to express that allotype in irradiated recipients and not 
transfer allotype information to another, genetically dissimilar, cell type (39). 
(b)  The assumptions  that thymus-influenced cells (T cells)  are susceptible to 
treatment  with  Anti  0  q-  GPS,  and  that  the  relevant  antibodies  in  AKR 
anti  C3H thymus cell sera  are the  anti  0C3H antibodies  (19;  Table I).  Our 
AKR/J  anti  C3H/HeJ  thymus  cell  antiserum  may contain  some  antibodie~ 
against imnmnoglobulins of the a type as determined by facilitation and inhibi- 
tion of passive hemagglutination (40). No antiallotype antibody is detectable 
using nSI-labeled 3'G2= and 2/G1 proteins of the a or b  type}  5 Certainly, in the 
present  system the  activity, if any,  of anti  a  allotype antibody is  unnoticed 
since full reconstitution of a B  cell-mediated response of C3H.SW is achieved 
with T  cells.  Moreover, the results are similar whether cells from C3H.SW or 
CWB are treated with Anti 0 -4- GPS. These or other antibodies, however, even 
if  present  in  low  amounts,  may  be  of  importance  in  fluorescent  antibody 
sandwich techniques.  1G 
If, in  the future, assumption  (a)  is  proven to be incorrect then  the inter- 
pretations of the present study, like many others, must be altered profoundly. 
In  the  absence of evidence to  the contrary we have assumed  that  the genes 
coding for the Fc immunoglobulin allotype markers  (and therefore the genes 
coding for the H  chain variable region if they are closely linked) are not trans- 
ferred between cell types in an artificial mixture of cells. On this point, prelimi- 
nary results of Hattis and Wegmann using allophenic mice indicate that spleen 
cells of a particular H-2 type in the chimaera will produce the predicted allo- 
type-marked anti SRBC immunoglobulin. 
There is only indirect evidence available on the question of whether 0-bearing 
peripheral lymphocytes are thymus-derived cells, or at least thymus-influenced 
cells. Athymic and surgically thymectomized mice contain relatively few 0-bear- 
ing cells (41) or cells sensitive to Anti 0 -4- GPS (18, 19). This could be a primary 
consequence of removal of the source of the influence required for the genera- 
tion of 0-bearing cells or a secondary consequence dependent upon some other 
factor. The results of the present study indicate that spleen cells sensitive to 
Anti 0 q-  GPS can be replaced by thynms cells,  a cell population known to be 
rich in 0-bearing cells (16,  17). 
15 Ravitch, M., and G. F. Mitchell. Unpublished data. 
16 Masuda, T., and G. F. Mitchell. Unpublished data. MITCHELL  ET  AL.  181 
The present data does not provide obvious clues on the role of T  cells in 
primary and secondary hemolytic antibody responses. Results of Miller et al. 
(42) and Taylor and Wortis (43) clearly indicate that indirect PFC production 
to SRBC is more thymus dependent than direct PFC production. This differ- 
ence in thymus dependence vs. quality of antibody elicited is very obvious in 
the  genetically  controlled,  H-2-1inked  antibody  response  to  the  synthetic 
polypeptide  antigen  (T,G)-A--L.  Thymectomized  (Tx)  or  sham  thymecto- 
mized  (STx)  C3H.SW  ("responders")  and  C3H  ("nonresponders")  produce 
similar  titers  of  19S  IgM  antibody in  the  1st wk  after injection of aqueous 
(T,G)-A--L.  After  booster  immunizations,  STx  C3H.SW,  unlike  their  Tx 
counterparts  and  either Tx or STx  C3H,  contain large  amounts  of  7S  anti 
(T,G)-A--L antibodyY The possibility exists that  an antigen-reactive B  cell 
population in the  absence of antigen-reactive T  cells responds abortively by 
producing antibody to certain antigens. An  abortive response may include a 
failure of recruitment of B  cells capable of responding by secreting IgG anti- 
bodies (B ~ cells)  or a failure of maturation of B~-cells  from precursors synthe- 
sizing IgM antibodies (B" cells). Confining speculation on the role of T  cells 
to two possibilities, it is conceivable that at least some types of B  cell require 
either  (a)  antigen  presentation  in  order  to  prevent  tolerance  induction  or 
promote immune induction or (b) a secreted or surface substance of T  cells to 
respond maximally by producing antibody. The data in this study show that 
in the absence of T  cells even primed B cells respond feebly by producing IgG 
antibodies to foreign erythrocyte antigens. 
SUMMARY 
Using  anti-allotype sera and AKR  anti 0C3H sera,  a  requirement for two 
cell types has been demonstrated in the adoptive secondary response of mice 
to  heterologous  erythrocytes.  The  cell  types  have  been  designated  B  cells 
[precursors  of  plaque-forming  cells  (PFC)]  and  T  cells  (thymus-influenced 
cells,  not providing precursors of detectable PFC). The in vivo indirect PFC 
response of spleen cells from primed mice is markedly reduced by in vitro treat- 
ment of the cells with a mixture of anti-0 serum and guinea pig serum (Anti 
0 +  GPS). This B  cell response is fully restored to control levels by thymus 
cells from normal mice which do not themselves provide precursors of indirect 
PFC. Thus memory is carried by the B cell lineage but  the  expression of this 
memory is dependent on the presence of a cell population which is sensitive to 
Anti 0 +  GPS and which is replaced functionally by unprimed T  cells.  When 
assayed for T  cell activity, thoracic duct cells from specifically primed mice 
are better than cells from nonspecifically primed mice in restoring the B  cell 
17 Mitchell, G. F., F. C. Grumett, and H. O. McDevitt. 1971. Influence of thymectomy on 
the primary immune response to the  synthetic polypeptide (T, G)-A--L. Manuscript in 
preparation. 182  IMMUNOLOGICAL MEMORY  IN  MICE.  III 
response of spleen cells from immunized mice. Moreover, the T  cell activity of a 
reconstitutive  cell population from primed mice is reduced by incubation with 
Anti 0 +  GPS. We conclude that memory to heterologous erythrocyte antigens 
is carried  by the  T  cell lineage  as well  as  the B  cell  lineage  even  though un- 
primed T  cells are sufficient for expression of B cell memory. 
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